The National Parkinson Foundation Welcomes New Board Member
MIAMI, August 21, 2015 — The National Parkinson Foundation (NPF) announced the election of a new member to its Board of Directors: Dr. Guido Goldman
"We are flattered that Dr. Goldman has joined NPF’s Board," stated John W. Kozyak, Esq., NPF Chairman of the Board. "He knows firsthand how Parkinson’s affects the whole family—his father had Parkinson’s—and he is passionate about our mission to make life better for people living with this disease. Dr. Goldman has an international reputation and years of service which will greatly help the foundation.”
Guido Goldman, PhD, was elected to the board in May 2015. Dr. Guido Goldman has been the Director of the Program for the Study of Germany at the Minda de Gunzburg Center for European Studies of Harvard University since 1989. He served as Director of the Minda de Gunzburg Center for European Studies from 1969 to 1994. Dr. Goldman has been Chairman of the Board and President of First Spring Corporation, engaged in private asset management since 1985. Dr. Goldman served as Co-Chairman of German Marshall Fund of the United States, of which he was the founder. He serves as a Member of American Advisory Board at Christie's International SA. He also served as chairman of the American Foundation for Textile Art, Inc., and as a vice chairman of the board of the Alvin Ailey American Dance Theater, and a board member of the American Council on Germany. The Dr. Guido Goldman Fellowship for the Study of German and European Economic and International Affairs, sponsored by the American Council on Germany, was established in 2003 to honor Dr. Goldman’s work in political science and his study of economics and foreign relations as they apply to transatlantic affairs.
About the National Parkinson Foundation (NPF)
Founded in 1957, the National Parkinson Foundation's mission is to make life better for people with Parkinson’s through expert care and research. NPF has funded more than $189 million in care, research and support services. For more information about NPF, visit www.parkinson.org, or call the NPF Helpline at 1-800-4PD-INFO (473-4636).
About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.